Does multiparametric MRI increase Oncologic outcomes in prostate cancer?
| Data(s) |
20/04/2016
20/04/2016
2015
|
|---|---|
| Resumo |
The purpose of this study is to compare the 4-year biochemical disease-free survival (BDFS) of patients with prostate cancer (PCa) staged according to multiparametric MRI (mpMRI) and treated with radical prostatectomy (RP) versus intensity-modulated radiation therapy (IMRT) ≥76 Gy ± hormonal therapy (HT). SIN FINANCIACIÓN 2.075 JCR (2015) Q3, 153/213 Oncology UEM |
| Identificador |
Couñago, F., del Cerro, E., Díaz Gavela, A., Rodríguez Luna, J. M., Marcos, F. J., Pérez-Coca, J., Thuissard, I. J., Olaciregui, K., Mateo, M., & Sanz-Rosa, D. (2015). Does multiparametric MRI increase Oncologic outcomes in prostate cancer? In: XVIII Congreso de la SEOR. Clinical & Translational Oncology, 17(extra. 1), 103. 1699048X 16993055 |
| Idioma(s) |
eng |
| Direitos |
openAccess |
| Palavras-Chave | #Próstata - Cáncer #Cáncer #Ciencias médicas |
| Tipo |
article |
